Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of DW5421A/DW5421B Compared to Monotherapy of DW5421A [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the combination DW5421A/DW5421B versus DW5421A monotherapy for primary hypercholesterolemia and mixed dyslipidemia, and the study has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Mixed Dyslipidemia

Drugs mentioned

• DW5421A
• DW5421B

Snippet

Sponsor: Daewon Pharmaceutical Co., Ltd. | Conditions: Primary Hypercholesterolemia, Mixed Dyslipidemia | Phase 3 | Status: COMPLETED